Working... Menu

ANAVEX2-73 for Treatment of Early Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03790709
Recruitment Status : Recruiting
First Posted : January 1, 2019
Last Update Posted : January 1, 2019
Anavex Australia Pty Ltd.
Information provided by (Responsible Party):
Anavex Life Sciences Corp.

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 31, 2020
  Estimated Study Completion Date : March 31, 2021